Literature DB >> 8482995

Deterioration or onset of migraine under oestrogen replacement therapy in the menopause.

H J Kaiser, O Meienberg.   

Abstract

Entities:  

Mesh:

Year:  1993        PMID: 8482995     DOI: 10.1007/bf00857528

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  7 in total

1.  Serotype of Campylobacter jejuni, HLA, and the Guillain-Barré syndrome.

Authors:  N Yuki; S Sato; S Fujimoto; S Yamada; Y Tsujino; A Kinoshita; T Itoh
Journal:  Muscle Nerve       Date:  1992-08       Impact factor: 3.217

2.  HLA-B35 and acute axonal polyneuropathy following Campylobacter infection.

Authors:  N Yuki; S Sato; T Itoh; T Miyatake
Journal:  Neurology       Date:  1991-10       Impact factor: 9.910

3.  Recurrent Guillain-Barré syndrome after multiple exposures to cytomegalovirus.

Authors:  M Donaghy; J A Gray; W Squier; J B Kurtz; R M Higgins; A J Richardson; P J Morris
Journal:  Am J Med       Date:  1989-09       Impact factor: 4.965

4.  Recurrent Guillain-Barré syndrome following influenza vaccine.

Authors:  M Seyal; D K Ziegler; J R Couch
Journal:  Neurology       Date:  1978-07       Impact factor: 9.910

5.  Relapsing neuropathy due to tetanus toxoid. Report of a case.

Authors:  J D Pollard; G Selby
Journal:  J Neurol Sci       Date:  1978-06       Impact factor: 3.181

6.  Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis.

Authors:  N Yuki; H Yoshino; S Sato; T Miyatake
Journal:  Neurology       Date:  1990-12       Impact factor: 9.910

7.  Acute relapsing Guillain-Barré syndrome after long asymptomatic intervals.

Authors:  E F Wijdicks; A H Ropper
Journal:  Arch Neurol       Date:  1990-01
  7 in total
  7 in total

1.  Headache and hormone replacement therapy in the postmenopausal woman.

Authors:  E Anne MacGregor
Journal:  Curr Treat Options Neurol       Date:  2009-01       Impact factor: 3.598

2.  Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1.

Authors:  Katharina Eikermann-Haerter; Ergin Dileköz; Chiho Kudo; Sean I Savitz; Christian Waeber; Michael J Baum; Michel D Ferrari; Arn M J M van den Maagdenberg; Michael A Moskowitz; Cenk Ayata
Journal:  J Clin Invest       Date:  2008-12-22       Impact factor: 14.808

Review 3.  Migraine headache in perimenopausal and menopausal women.

Authors:  E Anne MacGregor
Journal:  Curr Pain Headache Rep       Date:  2009-10

Review 4.  [Migraine and hormones: what can we be certain of?].

Authors:  U Bingel
Journal:  Schmerz       Date:  2008-02       Impact factor: 1.107

5.  The primary vascular dysregulation syndrome: implications for eye diseases.

Authors:  Josef Flammer; Katarzyna Konieczka; Andreas J Flammer
Journal:  EPMA J       Date:  2013-06-07       Impact factor: 6.543

Review 6.  Migraine in women: the role of hormones and their impact on vascular diseases.

Authors:  Simona Sacco; Silvia Ricci; Diana Degan; Antonio Carolei
Journal:  J Headache Pain       Date:  2012-02-26       Impact factor: 7.277

Review 7.  Migraine in menopausal women: a systematic review.

Authors:  Patrizia Ripa; Raffaele Ornello; Diana Degan; Cindy Tiseo; Janet Stewart; Francesca Pistoia; Antonio Carolei; Simona Sacco
Journal:  Int J Womens Health       Date:  2015-08-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.